Literature DB >> 10403142

Is psychotherapy an effective treatment for melancholia and other severe depressive states?

M E Thase1, E S Friedman.   

Abstract

The treatment of severe depression with psychotherapy, alone, is controversial. In this paper, we review the historical, conceptual, and empirical contexts of this controversy. In addition to work by others, we review recent work from our institute which has examined the psychobiological substrates of response to treatment in depressive subtypes. We examine the traditional categories that describe severe depressions. The features and psychobiological correlates of melancholia are discussed, as is the relationship between melancholia and aging. Research on treatment of melancholia and other severe depressive states with psychotherapies such as cognitive behavior therapy (CBT) and interpersonal psychotherapy (IPT) is reviewed in detail. We conclude that although some melancholic patients are responsive to IPT or CBT, there is not yet compelling evidence that melancholic patients respond to psychotherapy as well as they do to medications. The potentially mediating effects of hypercortisolism, alterations of sleep neurophysiology, and disturbances of information processing and regional cerebral metabolism represent fertile grounds for future investigation. We discuss the practical implications of the literature reviewed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403142     DOI: 10.1016/s0165-0327(99)00033-6

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  10 in total

Review 1.  A systematic review of the combined use of electroconvulsive therapy and psychotherapy for depression.

Authors:  Shawn M McClintock; Anna R Brandon; Mustafa M Husain; Robin B Jarrett
Journal:  J ECT       Date:  2011-09       Impact factor: 3.635

Review 2.  When are psychotherapy and pharmacotherapy combinations the treatment of choice for major depressive disorder?

Authors:  M E Thase
Journal:  Psychiatr Q       Date:  1999

3.  Decreased occipital cortical glutamate levels in response to successful cognitive-behavioral therapy and pharmacotherapy for major depressive disorder.

Authors:  Chadi G Abdallah; Mark J Niciu; Lisa R Fenton; Madonna K Fasula; Lihong Jiang; Anne Black; Douglas L Rothman; Graeme F Mason; Gerard Sanacora
Journal:  Psychother Psychosom       Date:  2014-08-06       Impact factor: 17.659

4.  Pretreatment cortisol levels predict posttreatment outcomes among older adults with depression in cognitive behavioral therapy.

Authors:  Jason M Holland; Alan F Schatzberg; Ruth O'Hara; Renee M Marquett; Dolores Gallagher-Thompson
Journal:  Psychiatry Res       Date:  2013-08-14       Impact factor: 3.222

Review 5.  [Affective disorders. The significance of psychotherapeutic approaches].

Authors:  M Berger; E L Brakemeier; C Klesse; E Schramm
Journal:  Nervenarzt       Date:  2009-05       Impact factor: 1.214

6.  A history of early life parental loss or separation is associated with successful cognitive-behavioral therapy in major depressive disorder.

Authors:  Mark J Niciu; Chadi G Abdallah; Lisa R Fenton; Madonna K Fasula; Anne Black; George M Anderson; Gerard Sanacora
Journal:  J Affect Disord       Date:  2015-08-19       Impact factor: 4.839

7.  Interpersonal psychotherapy: past, present and future.

Authors:  John C Markowitz; Myrna M Weissman
Journal:  Clin Psychol Psychother       Date:  2012-02-14

Review 8.  Depression and sleep: pathophysiology and treatment.

Authors:  Michael E Thase
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

9.  Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.

Authors:  Craig H Mallinckrodt; John G Watkin; Chaofeng Liu; Madelaine M Wohlreich; Joel Raskin
Journal:  BMC Psychiatry       Date:  2005-01-04       Impact factor: 3.630

10.  Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?

Authors:  Rita Kočárová; Jiří Horáček; Robin Carhart-Harris
Journal:  Front Psychiatry       Date:  2021-07-19       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.